Stock KOD KODIAK SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Kodiak Sciences Inc.

Equities

KOD

US50015M1099

Market Closed - Nasdaq
Other stock markets
 01:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
2.2 USD -1.79% Intraday chart for Kodiak Sciences Inc. -13.04% -27.63%
Jun. 13 Transcript : Kodiak Sciences Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-13-2024 08:00 AM
May. 15 Kodiak Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Transcript : Kodiak Sciences Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-13-2024 08:00 AM
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences
PR
Kodiak Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results
PR
Diabetic Retinopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
AQ
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy
PR
Kodiak Sciences Inc. Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy
CI
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform
PR
Kodiak Sciences Inc. Announces Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate Platform
CI
UBS Adjusts Kodiak Sciences Price Target to $5 From $3, Maintains Neutral Rating
MT
Barclays Raises Price Target on Kodiak Sciences to $3 From $2, Maintains Underweight Rating
MT
Transcript : Kodiak Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024
Sector Update: Health Care Stocks Rise Late Afternoon
MT
Sector Update: Health Care
MT
Top Midday Decliners
MT
Kodiak Sciences Shares Tumble After Wider-Than-Expected Q4 Loss
MT
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
PR
Kodiak Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kodiak Sciences Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KOD Stock
  4. News Kodiak Sciences Inc.